摘要 |
<p>The present invention relates to an administration schedule comprising the intravenous administration of a alpha-halogen-acryloyl distamycin derivative, or a pharmaceutically acceptable salt thereof. The above administration allows the treatment of a variety of tumors in mammals.</p> |